Erudio Healtherudio.com
Clinical trial · no report yet · Phase 1
NCT02071862 trial: what clinicians have said so far
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
- NCT02071862 ↗
- Completed
- Calithera Biosciences, Inc
- Focused size, estimated: 1–150 verified statements once built
We haven't built an HCP commentary report on NCT02071862 yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT02071862 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 4 posts on X, typically up to 18 once built |
The trial
ClinicalTrials.gov- Official title
- Ph1 Study of the Safety, PK, and PDn of Escalating Oral Doses of the Glutaminase Inhibitor CB-839, as a Single Agent and in Combination With Standard Chemotherapy in Patients With Advanced and/or Treatment-Refractory Solid Tumors
- Phase
- Phase 1
- Status
- Completed
- Conditions
- Solid Tumors; Triple-Negative Breast Cancer; Non Small Cell Lung Cancer; Renal Cell Carcinoma; Mesothelioma; Fumarate Hydratase (FH)-Deficient Tumors; Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST); Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal Stromal Tumors; Tumors Harboring Isocitrate Dehydrogenase-1 (IDH1) and IDH2 Mutations; Tumors Harboring Amplifications in the cMyc Gene
- Interventions
- CB-839; Pac-CB; CBE; CB-Erl; CBD; CB-Cabo
- Arms
- CB-839 · Experimental
- Pac-CB · Experimental
- CBE · Experimental
- CB-Erl · Experimental
- CBD · Experimental
- CB-Cabo · Experimental
- Enrollment
- 210
- Primary outcomes
- Safety and tolerability of CB-839: Incidence of adverse events
- Sponsor
- Calithera Biosciences, Inc
- Start
- Feb 2014
- Primary completion
- Mar 2019
- Results posted
- No
- Registry record
- NCT02071862 · updated Jul 20, 2022